Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 07:00 ET | Source: Evaxion

Evaxion out-licenses vaccine candidate EVX-B3 to MSD

MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further...
September 26, 2024 07:30 ET | Source: Evaxion Biotech

Evaxion significantly expands vaccine development collaboration with MSD

Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...